Aurora kinase B siRNA-loaded lactoferrin nanoparticles potentiate the efficacy of temozolomide in treating glioblastoma

被引：25

作者：

Kumari, Sonali ^{[1
]}

Bhattacharya, Dwaipayan ^{[2
]}

Rangaraj, Nandini ^{[3
]}

Chakarvarty, Sumana ^{[3
]}

Kondapi, Anand K. ^{[1
]}

Rao, Nalam M. ^{[2
]}

机构：

[1] Univ Hyderabad, Sch Life Sci, Dept Biotechnol & Bioinformat, Prof CR Rao Rd, Hyderabad 500046, Telangana, India

[2] CSIR, Indian Inst Chem Technol, Ctr Chem Biol, Hyderabad 500007, Telangana, India

[3] CSIR, CCMB, Uppal Rd, Hyderabad 500007, Telangana, India

来源：

NANOMEDICINE | 2018年 / 13卷 / 20期

关键词：

blood-brain barrier; glioblastoma multiforme; nanoparticle; siRNA; temozolomide; MEDIATED TARGETED DELIVERY; CANCER STEM-CELLS; LIPID NANOPARTICLES; SYSTEMIC DELIVERY; MOUSE MODEL; GENE; DNA; DRUG; PHARMACOKINETICS; PHOSPHORYLATION;

D O I：

10.2217/nnm-2018-0110

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Aim: To investigate the efficacy of lactoferrin nanoparticles (LfNPs) in delivering siRNA across the bloodbrain barrier to treat glioblastoma multiforme (GBM) and with an additional objective of potentiation of conventional temozolomide (TMZ) chemotherapy. Methods: Aurora kinase B (AKB) siRNA-loaded nanoparticles (AKB-LfNPs) were prepared with milk protein, lactoferrin, by water in oil emulsion method. AKB-LfNPs were tested in cell lines and in GBM orthotopic mouse model with and without TMZ treatment. Results: AKB silencing, cytotoxicity and cell cycle arrest by these LfNPs were shown to be effective on GL261 cells. Tumor growth was significantly lower in AKB-LfNPs alone and in combination with TMZ treated mice and increased the survival by 2.5-times. Conclusion: Treatment of AKB-LfNPs to GBM mice improves life expectancy and has potential to combine with conventional chemotherapy.

引用

页码：2579 / 2596

页数：18

共 6 条

[1] Development of siRNA-loaded chitosan nanoparticles targeting Galectin-1 for the treatment of glioblastoma multiforme via intranasal administration
Van Woensel, Matthias
Wauthoz, Nathalie
Rosiere, Remi
Mathieu, Veronique
Kiss, Robert
Lefranc, Florence
Steelant, Brecht
Dilissen, Ellen
Van Gool, StefaanW.
Mathivet, Thomas
Gerhardt, Holger
Amighi, Karim
De Vleeschouwer, Steven
JOURNAL OF CONTROLLED RELEASE, 2016, 227 : 71 - 81
[2] Efficacy of siRNA-loaded nanoparticles in the treatment of K-RAS mutant lung cancer in vitro
Gencer, Ayse
Baysal, Ipek
Nemutlu, Emirhan
Yabanoglu-Ciftci, Samiye
Arica, Betul
JOURNAL OF MICROENCAPSULATION, 2022, 39 (03) : 261 - 275
[3] Targeting Aurora kinase B attenuates chemoresistance in glioblastoma via a synergistic manner with temozolomide
Alafate, Wahafu
Wang, Maode
Zuo, Jie
Wu, Wei
Sun, Liangzhang
Liu, Chao
Xie, Wanfu
Wang, Jia
PATHOLOGY RESEARCH AND PRACTICE, 2019, 215 (11)
[4] Combined anti-Galectin-1 and anti-EGFR siRNA-loaded chitosan-lipid nanocapsules decrease temozolomide resistance in glioblastoma: In vivo evaluation
Danhier, Fabienne
Messaoudi, Khaled
Lemaire, Laurent
Benoit, Jean-Pierre
Lagarce, Frederic
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2015, 481 (1-2) : 154 - 161
[5] Genistein and Temozolomide-Loaded Polymeric Nanoparticles: A Synergistic Approach For Improved Anti-Tumor Efficacy Against Glioblastoma
Meteoglu, Irem
Erdemir, Aysegul
PROCESS BIOCHEMISTRY, 2021, 110 : 9 - 18
[6] Delivery of siRNA targeting HIF-1α loaded chitosan modified D-α-tocopheryl polyethylene glycol 1000 succinate-b-poly(ε-caprolactone-ran-glycolide) nanoparticles into nasopharyngeal carcinoma cell to improve the therapeutic efficacy of cisplatin
Lian, Daizheng
Chen, Yuhan
Xu, Gang
Zeng, Xiaowei
Li, Zhuangling
Li, Zihuang
Zhou, Yayan
Mei, Lin
Li, Xianming
RSC ADVANCES, 2016, 6 (44): : 37740 - 37749

← 1 →